title: Very-low and low-density lipoproteins induce neutral lipid accumulation and impair migration in monocyte subsets.
abstract: Blood monocytes are heterogeneous effector cells of the innate immune system. In circulation these cells are constantly in contact with lipid-rich lipoproteins, yet this interaction is poorly characterised. Our aim was to examine the functional effect of hyperlipidaemia on blood monocytes. In the Ldlr(-/-) mouse monocytes rapidly accumulate cytoplasmic neutral lipid vesicles during hyperlipidaemia. Functional analysis in vivo revealed impaired monocyte chemotaxis towards peritonitis following high fat diet due to retention of monocytes in the greater omentum. In vitro assays using human monocytes confirmed neutral lipid vesicle accumulation after exposure to LDL or VLDL. Neutral lipid accumulation did not inhibit phagocytosis, endothelial adhesion, intravascular crawling and transmigration. However, lipid loading led to a migratory defect towards C5a and disruption of cytoskeletal rearrangement, including an inhibition of RHOA signaling. These data demonstrate distinct effects of hyperlipidaemia on the chemotaxis and cytoskeletal regulation of monocyte subpopulations. These data emphasise the functional consequences of blood monocyte lipid accumulation and reveal important implications for treating inflammation, infection and atherosclerosis in the context of dyslipidaemia.
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.
authors.forename: William D
authors.initials: WD
authors.lastname: Jackson
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.|Department of Visual Neuroscience, Institute of Ophthalmology, University College London, UK.
authors.forename: Tobias W
authors.initials: TW
authors.lastname: Weinrich
authors.affiliation: Division of Immunology and Inflammation, Department of Medicine, Imperial College London, UK.
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Woollard
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D002465:Cell Movement / Q000187:drug effects; D003599:Cytoskeleton / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000378:metabolism; D016130:Immunophenotyping; D050356:Lipid Metabolism / Q000187:drug effects*; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008079:Lipoproteins, VLDL / Q000494:pharmacology*; D051379:Mice; D018345:Mice, Knockout; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism*; D010538:Peritonitis / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010587:Phagocytosis; D010641:Phenotype; D015398:Signal Transduction / Q000187:drug effects; D057705:Transendothelial and Transepithelial Migration
chemical_list: D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL
references.citation: J Clin Invest. 1999 Mar;103(5):613-25
references.pmid: 10074478
references.citation: J Lipid Res. 1999 Apr;40(4):680-5
references.pmid: 10191292
references.citation: J Cell Biol. 2001 Jul 9;154(1):147-60
references.pmid: 11448997
references.citation: J Biol Chem. 2003 Apr 11;278(15):13578-84
references.pmid: 12574166
references.citation: J Immunol. 2003 Mar 15;170(6):3223-32
references.pmid: 12626581
references.citation: J Lipid Res. 1964 Oct;5:624-7
references.pmid: 14221109
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11779-84
references.pmid: 15280540
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1596-602
references.pmid: 17495238
references.citation: J Lipid Res. 2008 Jul;49(7):1553-61
references.pmid: 18367731
references.citation: Infect Immun. 2008 Aug;76(8):3464-72
references.pmid: 18505807
references.citation: FASEB J. 2009 Mar;23(3):866-74
references.pmid: 19001052
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S86-90
references.pmid: 19033209
references.citation: BMC Med Genomics. 2008 Nov 28;1:60
references.pmid: 19040724
references.citation: Circulation. 2009 May 26;119(20):2708-17
references.pmid: 19433759
references.citation: Blood. 2010 Jan 21;115(3):e10-9
references.pmid: 19965649
references.citation: Science. 2010 Feb 5;327(5966):656-61
references.pmid: 20133564
references.citation: J Immunol. 2010 Apr 1;184(7):3927-36
references.pmid: 20208007
references.citation: Immunity. 2010 Sep 24;33(3):375-86
references.pmid: 20832340
references.citation: Circulation. 2010 Nov 9;122(19):1948-56
references.pmid: 20974996
references.citation: Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6
references.pmid: 21030716
references.citation: Circ Res. 2011 Jan 21;108(2):194-200
references.pmid: 21148432
references.citation: Physiol Rev. 2011 Jan;91(1):327-87
references.pmid: 21248169
references.citation: J Cell Sci. 2011 Mar 1;124(Pt 5):679-83
references.pmid: 21321325
references.citation: J Clin Invest. 2011 May;121(5):2025-36
references.pmid: 21505265
references.citation: Blood. 2011 Aug 4;118(5):e16-31
references.pmid: 21653326
references.citation: Blood. 2011 Sep 22;118(12):e50-61
references.pmid: 21803849
references.citation: Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):264-72
references.pmid: 22053073
references.citation: Nat Immunol. 2012 Jan 08;13(2):136-43
references.pmid: 22231519
references.citation: Eur J Immunol. 2012 Apr;42(4):957-74
references.pmid: 22531920
references.citation: Mol Biol Cell. 2012 Aug;23(16):3057-68
references.pmid: 22718904
references.citation: Cell. 2012 Sep 28;151(1):138-52
references.pmid: 23021221
references.citation: Nat Immunol. 2012 Nov;13(11):1118-28
references.pmid: 23023392
references.citation: Eur Heart J. 2013 Jun;34(24):1826-33
references.pmid: 23248205
references.citation: J Am Coll Cardiol. 2013 Jan 29;61(4):427-36
references.pmid: 23265341
references.citation: Curr Protoc Immunol. 2013;Chapter 14:Unit 14.33.1-16
references.pmid: 23564685
references.citation: Circ Res. 2013 May 24;112(11):1456-65
references.pmid: 23572498
references.citation: J Cell Biol. 1990 Sep;111(3):929-40
references.pmid: 2391369
references.citation: Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H109-20
references.pmid: 24163071
references.citation: Cell Immunol. 2014 May-Jun;289(1-2):135-9
references.pmid: 24791698
references.citation: Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2120-7
references.pmid: 25060791
references.citation: Front Immunol. 2014 Nov 12;5:579
references.pmid: 25429291
references.citation: Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1787-97
references.pmid: 26112011
references.citation: Cell Rep. 2015 Sep 22;12(11):1802-15
references.pmid: 26344769
references.citation: Annu Rev Biochem. 1980;49:667-93
references.pmid: 6996570
references.citation: Inflamm Res. 1995 Apr;44(4):169-77
references.pmid: 7545527
references.citation: Proc Natl Acad Sci U S A. 1994 May 10;91(10):4431-5
references.pmid: 8183926
references.citation: Infect Control Hosp Epidemiol. 1997 Jan;18(1):9-18
references.pmid: 9013240
references.citation: Nature. 1997 Jun 12;387(6634):729-33
references.pmid: 9192901
references.citation: Infect Immun. 1997 Jul;65(7):2663-7
references.pmid: 9199434
references.citation: Atherosclerosis. 1998 Jan;136(1):17-24
references.pmid: 9544727
references.citation: J Lipid Res. 1998 Sep;39(9):1740-3
references.pmid: 9741685